Bryan E. Smith
Compliance Officer at ELEDON PHARMACEUTICALS, INC.
Net worth: - $ as of 2024-03-30
Profile
Bryan E.
Smith is currently the Secretary, Compliance Officer & General Counsel at Eledon Pharmaceuticals, Inc. He previously worked as an Attorney at Gibson, Dunn & Crutcher LLP and Morrison & Foerster LLP.
He also served as the Associate Vice President & Senior Counsel at Allergan Ltd.
(Ireland) from 2011 to 2018.
From 2018 to 2021, he was the General Counsel at Urovant Sciences, Inc. and Urovant Sciences Ltd.
Mr. Smith received his undergraduate degree from Brigham Young University in 2005 and his graduate degree from the University of Southern California Gould School of Law in 2005.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2023-04-30 | 0 ( -.--% ) | - $ | 2024-03-30 |
Bryan E. Smith active positions
Companies | Position | Start |
---|---|---|
ELEDON PHARMACEUTICALS, INC. | Compliance Officer | 2021-04-18 |
Former positions of Bryan E. Smith
Companies | Position | End |
---|---|---|
UROVANT SCIENCES LTD. | General Counsel | 2021-03-31 |
Urovant Sciences, Inc.
Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The private company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | General Counsel | 2021-03-31 |
ALLERGAN PLC | Corporate Officer/Principal | 2018-03-31 |
Gibson, Dunn & Crutcher LLP
Gibson, Dunn & Crutcher LLP Miscellaneous Commercial ServicesCommercial Services Gibson, Dunn & Crutcher LLP provides legal services. It offers services to labor, employment, entertainment and media law, toxic torts and other environmental services. The company was founded in 1890 and is headquartered in Los Angeles, CA. | Corporate Officer/Principal | 2010-12-31 |
Morrison & Foerster LLP
Morrison & Foerster LLP Miscellaneous Commercial ServicesCommercial Services Morrison & Foerster LLP is a law firm that provides legal services on various industries, which include: litigation, financial services, intellectual property and technology, and transactional work, such as corporate, capital markets and real estate finance representations. The company was founded in 1883 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | 2007-12-31 |
Training of Bryan E. Smith
Brigham Young University | Undergraduate Degree |
University of Southern California Gould School of Law | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
ELEDON PHARMACEUTICALS, INC. | Health Technology |
Private companies | 5 |
---|---|
Gibson, Dunn & Crutcher LLP
Gibson, Dunn & Crutcher LLP Miscellaneous Commercial ServicesCommercial Services Gibson, Dunn & Crutcher LLP provides legal services. It offers services to labor, employment, entertainment and media law, toxic torts and other environmental services. The company was founded in 1890 and is headquartered in Los Angeles, CA. | Commercial Services |
Morrison & Foerster LLP
Morrison & Foerster LLP Miscellaneous Commercial ServicesCommercial Services Morrison & Foerster LLP is a law firm that provides legal services on various industries, which include: litigation, financial services, intellectual property and technology, and transactional work, such as corporate, capital markets and real estate finance representations. The company was founded in 1883 and is headquartered in San Francisco, CA. | Commercial Services |
Allergan Ltd. (Ireland)
Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
Urovant Sciences, Inc.
Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The private company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | Health Technology |
Urovant Sciences Ltd.
Urovant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Urovant Sciences Ltd. is a clinical-stage biopharmaceutical company, which through its subsidiaries, engages in the development and commercialization of therapies for urologic conditions. Its pipeline includes Vibegron (RVT-901) and URO-902. The company was founded on January 27, 2016 and is headquartered in London, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Bryan E. Smith